Managing dementia involves a combination of supportive care and pharmacological interventions designed to address cognitive decline and behavioral symptoms. While current treatments cannot cure the underlying disease, they are essential for improving quality of life and maintaining independence for as long as possible. In a clinical context, medications are primarily aimed at enhancing communication between brain cells or regulating chemicals that become unbalanced as neurons are damaged.
Choosing the right medication depends on the specific type of dementia, the severity of symptoms, and the individual’s overall health profile. Treatment plans are often reviewed regularly to ensure they remain effective and that any side effects are managed promptly. This guide provides an overview of the main classes of medication used in clinical practice and how they target different aspects of the condition.
what we will discuss in this article
- Cholinesterase inhibitors for memory and thinking
- The role of memantine in moderate to severe stages
- Managing behavioural and psychological symptoms (BPSD)
- Use of antidepressants and antipsychotics in dementia care
- The importance of non pharmacological approaches first
- Combining medications for enhanced symptom control
- emergency guidance for identifying signs of health deterioration
Cholinesterase inhibitors
These medications are typically the first line of treatment for mild to moderate Alzheimer disease, dementia with Lewy bodies, and Parkinson disease dementia.
There are three main drugs in this class:
- Donepezil
- Rivastigmine
- Galantamine
They work by preventing the breakdown of acetylcholine, a chemical messenger in the brain that is vital for memory, learning, and concentration. By increasing the levels of this neurotransmitter, these medicines can help stabilise or temporarily improve mental abilities. Donepezil is the most commonly prescribed, while rivastigmine may be preferred for those who experience visual hallucinations or require a skin patch if they have difficulty swallowing.
NMDA receptor antagonists (Memantine)
Memantine is a different type of medication used for people in the middle and later stages of Alzheimer disease or dementia with Lewy bodies.
Unlike cholinesterase inhibitors, memantine targets a chemical called glutamate. In a brain affected by dementia, glutamate can be produced in excessive amounts, which overstimulates and eventually damages brain cells. Memantine works by blocking the effects of this excess glutamate, protecting neurons and helping to reduce symptoms such as confusion, agitation, and difficulties with daily tasks. It is often prescribed to those who cannot tolerate other dementia drugs or as an add-on treatment to donepezil for those in the severe stages.
Managing behavioural symptoms (BPSD)
Behavioural and psychological symptoms of dementia, such as agitation, aggression, and psychosis, are often the most challenging aspects for families and clinicians to manage.
[Image showing non-pharmacological interventions like music therapy or light exercise]
Clinically, the first step is always to rule out physical causes like pain, infection, or dehydration. If symptoms remain severe and cause distress or risk of harm, medications may be considered:
- Antipsychotics: Risperidone is the only medication licensed for the short term treatment of persistent aggression in Alzheimer disease. These are used with extreme caution due to the risk of side effects.
- Antidepressants: Drugs like sertraline or trazodone may be used to manage depression, anxiety, or irritability, although the evidence for their effectiveness in dementia is more limited.
Comparison of primary dementia medications
| Medication Class | Common Drugs | Primary Use | Common Side Effects |
| Cholinesterase Inhibitors | Donepezil, Rivastigmine | Mild to moderate cognitive symptoms | Nausea, loss of appetite, vivid dreams |
| NMDA Antagonists | Memantine | Moderate to severe cognitive symptoms | Dizziness, headache, constipation |
| Antipsychotics | Risperidone | Severe aggression and distress | Drowsiness, increased risk of stroke |
| Antidepressants | Sertraline, Trazodone | Depression and anxiety | Dry mouth, dizziness, sleep changes |
The clinical review process
Medication for dementia is not a set and forget intervention. It requires ongoing clinical monitoring to ensure the benefits outweigh the risks.
A typical review involves assessing cognitive scores, checking for side effects, and discussing behavioural changes with carers. For medications like antipsychotics, reviews should happen at least every six weeks to see if the dose can be reduced or the drug stopped. The goal of medication is to support the person’s ability to engage with their surroundings and maintain their dignity throughout the progression of the condition.
To summarise
Medicines play a vital role in managing the symptoms of dementia, from enhancing memory and concentration to calming severe agitation. While cholinesterase inhibitors and memantine are the mainstays of cognitive support, behavioural symptoms often require a more cautious, multi modal approach. It is essential for patients and carers to work closely with their medical team to find the most effective combination of treatments. By focusing on targeted symptom management, clinicians can help individuals with dementia live more comfortably and maintain their independence for longer.
emergency guidance
Acute changes in behaviour or physical health in a person with dementia require immediate clinical assessment. Call 999 or seek urgent help if you notice signs of a stroke (facial drooping, arm weakness, or slurred speech) or if the person experiences a sudden onset of profound confusion, which may indicate delirium from a severe infection. Additionally, seek emergency care if there is a suspected adverse reaction to an antipsychotic, such as extreme muscle stiffness, high fever, or rapid breathing. Any sudden inability to swallow or a significant fall resulting in injury also constitutes a medical emergency.
Do these medicines stop dementia from getting worse?
No. Current medications manage symptoms but do not stop the underlying disease process.
Can a person take donepezil and memantine together?
Yes. Combining these two drugs is common in the moderate to severe stages and can provide better symptom control than either drug alone.
Are there drugs for vascular dementia?
There are currently no medications specifically licensed for vascular dementia, but drugs for Alzheimer are sometimes used if the person has a mixed diagnosis.
What if my relative can no longer swallow tablets?
Some medications, like rivastigmine, are available as skin patches, and others come in liquid or dispersible (melt in the mouth) forms.
How long do these medicines work for?
The duration of benefit varies, but many people find they help for six to twelve months, and sometimes longer.
Are there any new drugs coming soon?
New treatments that target the proteins in the brain are being researched, and some have received limited approval for early stage Alzheimer disease in specific clinical settings.
Authority Snapshot
Dr. Rebecca Fernandez is a UK trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence based approaches such as CBT, ACT, and mindfulness based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well being.
